Bullboard - Stock Discussion Forum Mind Medicine (MindMed) Inc N.MMED.WR

Primary Symbol: MNMD Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more

Add To Watchlist

NDAQ:MNMD - Post Discussion

Mind Medicine (MindMed) Inc > Looks like MMD is ready to open open up the valves

View:

Post by TheTerminator1 on Jun 10, 2021 7:35am

Looks like MMD is ready to open open up the valves

https://thedalesreport.com/psychedelics/mindmed-announces-chief-executive-officer-transition/

Excerpt:

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED), a leading clinical-stage pharmaceutical company and pioneer in the field of psychedelic inspired medicines, announces that J.R. Rahn, the Company’s co-founder and chief executive officer, is stepping down as chief executive officer and a director, and that its chief development officer, Robert Barrow, will assume the position of chief executive officer with immediate effect. The Company will also initiate a comprehensive search for a chief executive officer, in which Mr. Barrow will be a candidate, and Mr. Rahn will advise the Company during its leadership transition. The transition of the Company’s leadership team will enable the Company to pursue aggressively its clinical development programs and development of its companion innovative digital technologies.

580